BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22451318)

  • 1. CB1 agonist ACEA protects neurons and reduces the cognitive impairment of AβPP/PS1 mice.
    Aso E; Palomer E; Juvés S; Maldonado R; Muñoz FJ; Ferrer I
    J Alzheimers Dis; 2012; 30(2):439-59. PubMed ID: 22451318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
    Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
    J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid Receptor Type 1 Agonist ACEA Improves Cognitive Deficit on STZ-Induced Neurotoxicity Through Apoptosis Pathway and NO Modulation.
    Crunfli F; Vrechi TA; Costa AP; Torrão AS
    Neurotox Res; 2019 Apr; 35(3):516-529. PubMed ID: 30607903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset.
    Dionísio PA; Amaral JD; Ribeiro MF; Lo AC; D'Hooge R; Rodrigues CM
    Neurobiol Aging; 2015 Jan; 36(1):228-40. PubMed ID: 25443293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in AβPP/PS1 mice.
    Aso E; Juvés S; Maldonado R; Ferrer I
    J Alzheimers Dis; 2013; 35(4):847-58. PubMed ID: 23515018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
    Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arachidonyl-2-Chloroethylamide Alleviates Cerebral Ischemia Injury Through Glycogen Synthase Kinase-3β-Mediated Mitochondrial Biogenesis and Functional Improvement.
    Bai F; Guo F; Jiang T; Wei H; Zhou H; Yin H; Zhong H; Xiong L; Wang Q
    Mol Neurobiol; 2017 Mar; 54(2):1240-1253. PubMed ID: 26820679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.
    Aso E; Andrés-Benito P; Carmona M; Maldonado R; Ferrer I
    J Alzheimers Dis; 2016; 51(2):489-500. PubMed ID: 26890764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer's disease.
    Onishi T; Iwashita H; Uno Y; Kunitomo J; Saitoh M; Kimura E; Fujita H; Uchiyama N; Kori M; Takizawa M
    J Neurochem; 2011 Dec; 119(6):1330-40. PubMed ID: 21992552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Acute Activation of the CB1 Receptor in the Hippocampus Decreases Neurotoxicity and Prevents Spatial Memory Impairment in Rats Lesioned with β-Amyloid 25-35.
    Patricio-Martínez A; Sánchez-Zavaleta R; Angulo-Cruz I; Gutierrez-Praxedis L; Ramírez E; Martínez-García I; Limón ID
    Neuroscience; 2019 Sep; 416():239-254. PubMed ID: 31400487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
    Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
    J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Puerarin alleviates cognitive impairment and oxidative stress in APP/PS1 transgenic mice.
    Zhou Y; Xie N; Li L; Zou Y; Zhang X; Dong M
    Int J Neuropsychopharmacol; 2014 Apr; 17(4):635-44. PubMed ID: 24345484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACEA (a highly selective cannabinoid CB1 receptor agonist) stimulates hippocampal neurogenesis in mice treated with antiepileptic drugs.
    Andres-Mach M; Haratym-Maj A; Zagaja M; Rola R; Maj M; Chrościńska-Krawczyk M; Luszczki JJ
    Brain Res; 2015 Oct; 1624():86-94. PubMed ID: 26225920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice.
    Arendash GW; Mori T; Cao C; Mamcarz M; Runfeldt M; Dickson A; Rezai-Zadeh K; Tane J; Citron BA; Lin X; Echeverria V; Potter H
    J Alzheimers Dis; 2009; 17(3):661-80. PubMed ID: 19581722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-amyloid and ATP-induced diffusional trapping of astrocyte and neuronal metabotropic glutamate type-5 receptors.
    Shrivastava AN; Kowalewski JM; Renner M; Bousset L; Koulakoff A; Melki R; Giaume C; Triller A
    Glia; 2013 Oct; 61(10):1673-86. PubMed ID: 23922225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocatechuic acid improves cognitive deficits and attenuates amyloid deposits, inflammatory response in aged AβPP/PS1 double transgenic mice.
    Song Y; Cui T; Xie N; Zhang X; Qian Z; Liu J
    Int Immunopharmacol; 2014 May; 20(1):276-81. PubMed ID: 24667368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mitochondrial permeability transition pore opening contributes to cannabinoid type 1 receptor agonist ACEA-induced neuroprotection.
    Ma L; Niu W; Yang S; Tian J; Luan H; Cao M; Xi W; Tu W; Jia J; Lv J
    Neuropharmacology; 2018 Jun; 135():211-222. PubMed ID: 29574098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Asarone inhibits neuronal apoptosis via the CaMKII/CREB/Bcl-2 signaling pathway in an in vitro model and AβPP/PS1 mice.
    Wei G; Chen YB; Chen DF; Lai XP; Liu DH; Deng RD; Zhou JH; Zhang SX; Li YW; Lii H; Liu LF; Wang Q; Nie H
    J Alzheimers Dis; 2013; 33(3):863-80. PubMed ID: 23064259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
    Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
    J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.